Liana Martirosyan

Summary

Publications

  1. doi request reprint Development of a minimal set of prescribing quality indicators for diabetes management on a general practice level
    Liana Martirosyan
    Department of Clinical Pharmacology, University Medical Center Groningen, University of Groningen, The Netherlands
    Pharmacoepidemiol Drug Saf 21:1053-9. 2012
  2. pmc The community impact of the 2009 influenza pandemic in the WHO European region: a comparison with historical seasonal data from 28 countries
    Liana Martirosyan
    Netherlands Institute for Health Services Research NIVEL, Utrecht, The Netherlands
    BMC Infect Dis 12:36. 2012
  3. pmc Methods to identify the target population: implications for prescribing quality indicators
    Liana Martirosyan
    Department of Clinical Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
    BMC Health Serv Res 10:137. 2010
  4. pmc A pilot qualitative study to explore stakeholder opinions regarding prescribing quality indicators
    Liana Martirosyan
    Department of Clinical Pharmacology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands
    BMC Health Serv Res 12:191. 2012
  5. doi request reprint A systematic literature review: prescribing indicators related to type 2 diabetes mellitus and cardiovascular risk management
    Liana Martirosyan
    Department of Clinical Pharmacology, University Medical Centre Groningen, University of Groningen, The Netherlands
    Pharmacoepidemiol Drug Saf 19:319-34. 2010

Detail Information

Publications5

  1. doi request reprint Development of a minimal set of prescribing quality indicators for diabetes management on a general practice level
    Liana Martirosyan
    Department of Clinical Pharmacology, University Medical Center Groningen, University of Groningen, The Netherlands
    Pharmacoepidemiol Drug Saf 21:1053-9. 2012
    ..To identify the relevant prescribing quality domains of type 2 diabetes mellitus care as a basis for the selection of a minimal set of prescribing quality indicators from a set of previously validated indicators...
  2. pmc The community impact of the 2009 influenza pandemic in the WHO European region: a comparison with historical seasonal data from 28 countries
    Liana Martirosyan
    Netherlands Institute for Health Services Research NIVEL, Utrecht, The Netherlands
    BMC Infect Dis 12:36. 2012
    ..This study aimed to compare the timing, geographic spread and community impact during the winter wave of influenza pandemic A (H1N1) 2009 to historical influenza seasons in countries of the WHO European region...
  3. pmc Methods to identify the target population: implications for prescribing quality indicators
    Liana Martirosyan
    Department of Clinical Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
    BMC Health Serv Res 10:137. 2010
    ..We compared these two approaches regarding the outcome of the prescribing quality assessment and their ability to identify treated and undertreated patients...
  4. pmc A pilot qualitative study to explore stakeholder opinions regarding prescribing quality indicators
    Liana Martirosyan
    Department of Clinical Pharmacology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands
    BMC Health Serv Res 12:191. 2012
    ..Knowledge regarding the opinions and preferences of all involved parties regarding prescribing quality information is important for effective use of prescribing quality indicators...
  5. doi request reprint A systematic literature review: prescribing indicators related to type 2 diabetes mellitus and cardiovascular risk management
    Liana Martirosyan
    Department of Clinical Pharmacology, University Medical Centre Groningen, University of Groningen, The Netherlands
    Pharmacoepidemiol Drug Saf 19:319-34. 2010
    ..Valid prescribing indicators (PI) are needed for reliable assessment of prescribing quality. The purpose of this study is to describe the validity of existing PI for type 2 diabetes mellitus and cardiovascular risk management...